Introduction
Core temperature is amongst the most rigorously regulated physiological parameters. The dominant thermoregulatory controller in humans is the hypothalamus, although temperature signals are integrated at numerous levels within the neuroaxis [1] . Core temperature at any given time of day is usually maintained within ഠ0.2°C of the target temperature by autonomic and behavioural thermoregulatory defences [2] . The major autonomic defences are sweating and active precapillary vasodilation [3] , arteriovenous shunt vasoconstriction [4] and shivering [5] . The core temperature triggering each defence (at a given skin temperature) defines the response threshold [6] . Temperatures between the sweating and vasoconstriction thresholds do not trigger autonomic thermoregulatory defences and define the interthreshold range.
Fever is by far the most common thermal disturbance. It differs from all others in being a regulated increase in designated body temperature resulting from release of endogenous pyrogens [7] . The second most common cause of thermal disturbances is drug- induced central thermoregulatory failure. General anaesthesia is the typical cause [8] , although regional anaesthesia [9] , sedatives [10] , alcohol [11] and opioids [12] also impair thermoregulatory control. Hypothermia results when thermoregulation fails in a normal or cool environment; in contrast, hyperthermia results from regulatory failure in a warm or hot environment. Poikilothermia syndrome is a rare cause of intrinsic thermoregulatory failure. Patients with this syndrome regulate body temperature poorly, if at all. As a result, core temperature varies over a range of 2-6°C depending on environmental conditions. This range far exceeds the normal daily temperature range [13] and may be associated with serious complications. Even mild hyperthermia, for example, may be associated with extreme tachycardia which often responds poorly to drug treatment. Similarly, only 2°C hypothermia markedly decreases resistance to infection [14] , prolongs post-anaesthetic recovery [15] , causes coagulopathies [16] and doubles the incidence of morbid cardiac outcomes [17] .
CASE REPORT
Only a few cases of poikilothermia syndrome have been reported, and most apparently resulted from hypothalamic strokes or tumours [18, 19] . The effects of heat or cold exposure have been evaluated in some patients with poikilothermia [18] , but few have undergone formal thermoregulatory evaluation. Recently, a patient was referred to us who had clinical evidence of poikilothermia syndrome, as well as long-standing multiple sclerosis. This combination has been reported once previously, but was not accompanied by a full thermoregulatory evaluation [20] . We therefore determined this patient's major autonomic response thresholds, using an established thermoregulatory testing protocol [10] .
The effect of core temperature perturbations on psychomotor function remains poorly understood [21, 22] . The major reason for this is that thermal manipulations normally provoke intense behavioural and autonomic defences -which both impair testing and restrict further decrease in core temperature. As a result, the temperature range in studies of normal, unmedicated humans barely exceeds 1°C, and all are confounded by simultaneous discomfort and shivering. Neither response, of course, restricts evaluation in patients with poikilothermia syndrome. Furthermore, the permissible temperature range is far greater than normal. We thus took this opportunity to evaluate the effects of core temperature changes on cognitive performance.
Case report
The subject of this report is a 63-year-old man with a 15-year-long history of multiple sclerosis. Manifestations of the syndrome have been characteristic for the chronic-progressive form, and he has now been wheelchair-bound 12 years.
Radiological evaluation has included numerous computerized tomography scans and magnetic resonance imaging studies, both of which were repeated last year. Each showed the characteristic whitematter lesions of multiple sclerosis diffusely distributed throughout the brain and spinal cord. However, none revealed any abnormality of the hypothalamus. Ten years ago, the patient developed difficulty controlling body temperature. Thermal instability developed abruptly and was not accompanied by worsening of his multiple sclerosis or by any other apparent medical event. His difficulty with thermal management has persisted, but not worsened, since. His oral temperatures are typically near 34.8°C but decrease to as low as 32.8°C in cool environments, and increase to 35.5°C during heat exposure or febrile illness. (Normal core body temperature ranges from 36.5 to 37.5°C depending on the time of day [13] ). The patient reports that body temperatures exceeding 35.5°C are associated with pronounced muscle weakness. In contrast, muscular strength improves with hypothermia -although his cognitive function declines at core temperatures below 33°C.
The patient's health is otherwise fairly good. He has mild hypertension, easily controlled with a calcium-channel blocker and diuretics. Five years ago he suffered a bout of aplastic anaemia accompanied by symptoms of dysarthria, sleepiness, organic mental syndrome and a decrease in his body temperature to 31.5°C. An aetiology was never clearly established, and the syndrome was finally attributed to an idiopathic drug reaction. It resolved fully without specific treatment beyond active cutaneous warming and cessation of all drugs; it has not recurred.
The patient has no liver or renal disease, and his family history is unremarkable. Medications include baclofen (60 mg day Ϫ1 ), mandlamin (2 g day Ϫ1 ), dilacor (240 mg day In mid-1995, the patient was referred to the Thermoregulation Research Laboratory at the University of California in San Francisco for evaluation of temperature instability. Evaluation was postponed because of a transient ischaemic attack in October of that year. Full neurological evaluation and magnetic resonance imaging failed to identify an accompanying stroke. Furthermore, echo and Doppler studies revealed that the patent's carotid arteries were without evidence of plaque or calcifications. Additional evaluation also failed to identify intracardiac clots or arrythmias.
Evaluation protocol
Thermoregulatory testing was carried out in June of 1996 between 8.30 and 20.30 h The consenting subject was minimally clothed and rested supine in an ഠ22°C room. Skin and core temperatures were first gradually increased with a forced-air warmer and circulating-water mattress until sweating was observed. Skin and core temperatures were then gradually decreased using circulating-water and forced-air cooling until vasoconstriction and shivering were detected. Skin temperature changes were restricted to less than 3°h Ϫ1 because this value is unlikely to trigger dynamic thermoregulatory responses [2] .
Core temperatures were recorded from a thermocouple touching the tympanic membrane. Cotton was then inserted into the aural canal, and the entire ear covered with a gauze bandage. We have previously shown that these measurements correlate well with distal oesophageal temperatures [23] . Mean skin surface temperature was calculated from measurements at 15 area-weighted sites [10] .
Temperatures were recorded at 5-min intervals from thermocouples connected to Iso-Thermex ® thermometers having an accuracy of 0.1°C (Columbus Instruments Corp., Columbus, OH). Thermal comfort was evaluated at ഠ0.5°C core-temperature intervals using a 100-mm-long visual analogue scale. A score of zero defined the worst imaginable cold, 50 mm identified thermal comfort, and 100 mm defined unbearable heat [24] .
Sweating was continuously quantified on the left upper chest using a ventilated capsule [25] . A sustained sweating rate exceeding 40 g m Ϫ2 h Ϫ1 was considered significant [10] . Absolute blood flow was quantified by venous-occlusion volume plethysmography in the right middle fingertip at 5-min intervals [26] . A sustained decrease in fingertip blood flow, as determined by a blinded observer, was considered substantial vasoconstriction.
As in previous similar studies, we used electromyographic activity [27] to quantify shivering. Following mild skin abrasion and degreasing, silver/silver chloride monitoring electrodes were positioned to record the electrical activity of the right pectoralis and trapezius, and the quadriceps bilaterally. The active electrodes were positioned 4 cm apart and orientated in the direction of the muscle fibres [28] . After appropriate amplification (Model P511 amplifier, Grass Instruments, Quincy, MA), the signals were recorded on a thermoelectric printer. Onset of shivering was subsequently determined by an investigator blinded to core temperature: sustained, synchronous waxing-and-waning activity identified significant shivering [5] .
Core temperature thresholds are defined at a constant skin temperature. Consequently, it is necessary to compensate for changes in skin temperature during thermoregulatory testing. Because the cutaneous contributions to sweating [29] and to vasoconstriction and shivering [30] are linear, we used measured skin and core temperatures in ºC at each threshold to calculate the core-temperature threshold that would have been observed had skin been maintained at a single designated temperature:
where the fractional contribution of mean skin temperature to the threshold was termed ␤. T core (calculated) thus equals the measured core temperature, T core , plus a small correction factor consisting of ␤/(1 Ϫ ␤) multiplied by the difference between actual (T skin ) and designated (T skin (designated) ) skin temperatures. We have previously described the derivation, validation and limitations of this equation [10] . We used ␤ ϭ 0.1 for sweating [29] and ␤ ϭ 0.2 for vasoconstriction and shivering [30] . The designated skin temperature was set at 34°C, a typical value.
A modification of the Montefiore Organic Brain Syndrome protocol was used for neuropsychological evaluation. This protocol includes tests of short-term memory, long-term memory, language comprehension and arithmetic. The tests were performed in the same order, after every 1°C change in core temperature.
Results
The subject weighed 107 kg and was 188 cm tall. His initial tympanic membrane temperature was 34.6°C. He was alert, cooperative and conversed with the investigators throughout the study. No changes in psychometric function were observed at any tested temperature, although he became noticeably dysarthric when core temperature decreased to Ͻ 33°C. The patient complained of feeling weak at core temperatures Ͼ 36°C, but easily maintained a normal respiratory pattern. Thermal comfort decreased nearly linearly from ഠ95 to ഠ15 mm as core temperature decreased from 38 to 32°C (Fig. 1) .
The calculated sweating threshold was 38.3°C (normal: 37.0 Ϯ 0.3°C). The vasoconstriction threshold was 34.4°C (normal: 36.4 Ϯ 0.3°C). The sweating-to-vasoconstriction interthreshold range was thus ഠ4°C, which is between 10 and 20 times the normal value. The shivering threshold was 31.8°C (normal: 35.6 Ϯ 0.3°C). The vasoconstriction-to-shivering range was thus ഠ2.5°C, which is more than twice the normal value (Table 1) .
Discussion
Core temperature deviations 10-20 times normal were required to trigger protective thermoregulatory defences in our patient. Formal thermoregulatory testing thus clearly indicates that he has poikilothermia. Equally interesting, however, is the fact that sufficient core-temperature perturbations did trigger autonomic responses. This pattern of impairment is consistent with the rostral-to-caudal system of progressively more precise thermoregulatory control centres proposed by Satinoff [1] . In this system, even complete inhibition of hypothalamic control fails to obliterate thermoregulatory control because sufficient temperature deviations activate 'lower' centres that provide some protection against further thermal perturbations.
Poikilothermia syndrome is thought to result from a defect at the level of the hypothalamus, and structural problems can usually be identified radiologically [18] . Although not apparent on magnetic resonance scanning, it is likely that the defect in our patient also was in the hypothalamus.
There was a progressive and nearly linear decrease in thermal comfort during induction of hypothermia. A distinct limitation of these data, though, is that we do not have 'control' measures and thus do not know how hypothermia normally affects thermal comfort. Nonetheless, behavioural thermoregulatory function (i.e. sensation of cold) appears to have been reasonably well preserved, which is in distinct contrast to the notable impairment of autonomic responses. Behavioural regulation is thought to origi- Table 1 Thermoregulatory thresholds. Measured core and mean skin temperatures, and the calculated thresholds at a designated mean skin temperature of 34°C. Results are presented as individual values from the subject of this report or as means Ϯ SD (last column) from a previous similar study [10] Mean 1 Thermal comfort was evaluated using a 100-mm-long visual analogue scale (VAS). A score of zero defined the worst imaginable cold, 50 mm identified thermal comfort, and 100 mm defined unbearable heat. Measurements were obtained by asking the subject to score his perception of his temperature periodically during gradual cooling from a core temperature of approximately 38-32°C. There was a nearly linear relationship between the score (about 95-15 mm) and the core temperature (from 38 to 32°C), indicating that subjective assessment of body temperature was relatively well preserved.
nate largely from the posterior hypothalamus, whereas autonomic control emanates mostly from the anterior pre-optic region. It is thus likely that this patient's damage was centred in the anterior region of the hypothalamus. An interesting aspect of this case is that the pattern of thermoregulatory impairment resembled that produced by general anaesthesia. Anaesthetics slightly increase the sweating threshold and markedly decrease the vasoconstriction and shivering thresholds [10, 31] . They thus increase the interthreshold range in a concentration-dependent fashion, with the increase usually being 10-to 20-fold, as in our patient. It is likely that anaesthetics inhibit thermoregulatory control at the level of the hypothalamus [32, 33] , thus leaving lower centres to activate defences -but in a considerably less precise fashion than is normally the case. Presumably, similar inhibition of hypothalamic regulation caused the observed thermoregulatory defect in our patient.
In general, hypothermia causes a global slowing of organ function. It decreases metabolic rate (in the absence of shivering and non-shivering thermogenesis), thus diminishing most physiological functions [34] . Nerve conduction decreases, but peripheral muscle tone increases, resulting in rigidity and myoclonus [35] . Symptoms attributed to hypothermia include decreased mentation, lethargy and ataxia. However, so little hypothermia can be induced in normal subjects that available data are limited [21, 22] . Thus an additional interesting aspect of this case is that cognitive function was at least grossly preserved, even at core temperatures approaching 32°C. Our observation thus suggests that mild hypothermia per se does not markedly impair thought processing. This result is consistent with a previous study conducted in volunteers over a smaller temperature range [36] .
Sensitivity to heat is common amongst patients with chronic progressive multiple sclerosis. Many of these patients develop neurological symptoms after hyperthermia, such as motor weakness, dysarthria, amblyopia and visual field defects [37] . In contrast, these disorders improve during and after cold exposure, and patients with multiple sclerosis often find that swimming in cool water improves their strength [38] . The fourth interesting aspect of this case is therefore that chronic hypothermia (ഠ35°C) associated with poikilothermia appears to be beneficial in our patient.
In summary, we present a patient with multiple sclerosis and poikilothermia syndrome. The coretemperature perturbations required to trigger his thermoregulatory defences were 10-20 times greater than normal. This pattern of impairment resembles that produced by general anaesthesia. Interestingly, this patient's behavioural thermoregulatory defences and cognitive function remained relatively intact -even at core temperatures near 32°C.
